4 Recruiting Recurrent Mantle Cell Lymphoma Phase 1 Clinical Trials
Active phase 1 studies for recurrent mantle cell lymphoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Recurrent Mantle Cell Lymphoma studiesPhase 1 Studies for Recurrent Mantle Cell Lymphoma
🔵 Active, Not Recruiting Phase1 / Phase2
Copanlisib and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1
Ibrutinib and Palbociclib in Treating Patients With Previously Treated Mantle Cell Lymphoma
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase1 / Phase2
Golcadomide in Combination With Rituximab for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase1
Pacritinib in Combination With a BTK Inhibitor for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔